Publication | Closed Access

Erlotinib in combination with pemetrexed/cisplatin for leptomeningeal metastases and cerebrospinal fluid drug concentrations in lung adenocarcinoma patients after gefitinib faliure

Leptomeningeal MetastasesMedicineLung Adenocarcinoma PatientsPharmacologyPharmacotherapyAnti-cancer AgentCancer TreatmentGefitinib FaliureOncologyRadiation OncologyLung Cancer